SHE:002603 Revenue

Shijiazhuang Yiling Pharmaceutical had revenue of 2.44B CNY in the quarter ending March 31, 2026, with 1,556.41% growth. This brings the company's revenue in the last twelve months to 6.01B, down -25.83% year-over-year. In the year 2024, Shijiazhuang Yiling Pharmaceutical had annual revenue of 6.51B, down -36.88%.

Revenue (ttm)

6.01B

Revenue Growth

-25.83%

P/S Ratio

4.73

Revenue / Employee

513.74K

Employees

11,708

Market Cap

28.44B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.51B	-3.81B	-36.88%
Dec 31, 2023	10.32B	-2.21B	-17.67%
Jan 1, 2023	12.53B	2.42B	23.88%
Jan 1, 2022	10.12B	1.33B	15.19%
Dec 31, 2020	8.78B	2.96B	50.76%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jan 1, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Humanwell Healthcare (Group)	23.96B
Livzon Pharmaceutical Group	11.71B
Changchun High-Tech Industry (Group)	11.67B
Zhejiang Huahai Pharmaceutical	8.71B
Dong-E-E-Jiao	6.80B
Hubei Jumpcan Pharmaceutical	5.90B
Kangmei Pharmaceutical	5.25B
Tianjin Pharmaceutical Da Ren Tang Group Corporation	4.92B

Revenue Rankings